News
Johnson & Johnson Vision Announces FDA Approval of ACUVUE® Abiliti™ Overnight Therapeutic Lenses for
Johnson & Johnson Vision Announces FDA Approval of ACUVUE® Abiliti™ Overnight Therapeutic Lenses for
November 20, 2023
Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies†, announced that the U.S. Food and Drug Administration (FDA) has approved ACUVUE® Abiliti™ Overnight Therapeutic Lenses. This is the first and only FDA-approved orthokeratology (ortho-k) contact lens for the management of myopia.